Adagene (ADAG) Liabilities and Shareholders Equity (2019 - 2026)
Adagene (ADAG) recorded Liabilities and Shareholders Equity of $133.58 million in the quarter ended Jun 30, 2026, up 100.8% from $66.52 million a year earlier.
Powered by 
Analysis
Adagene (ADAG) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, Adagene reported Liabilities and Shareholders Equity of $78.26 million, down 12.3% from the prior year.
- Annual Liabilities and Shareholders Equity has declined for four straight years, with a five-year compound annual growth rate of -1.5% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $89.27 million in the year ended Dec 31, 2024 (-22.9%), $115.73 million in the year ended Dec 31, 2023 (-24.1%), $152.4 million in the year ended Dec 31, 2022 (-19.6%) and $189.51 million in the year ended Dec 31, 2021 (+124.9%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Liabilities and Shareholders Equity since the quarter ended Jun 30, 2023.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in 1 of the last four quarters, with growth averaging 7.9%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 124.9% in the quarter ended Dec 31, 2021, against a decline of 34.0% in the quarter ended Jun 30, 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Adagene | 189.54 Mn | 189.54 Mn | - | 133.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.58 Mn |
| Dec 31, 2025 | 78.26 Mn |
| Jun 30, 2025 | 66.52 Mn |
| Dec 31, 2024 | 89.27 Mn |
| Jun 30, 2024 | 100.78 Mn |
| Dec 31, 2023 | 115.73 Mn |
| Jun 30, 2023 | 135.30 Mn |
| Dec 31, 2022 | 152.40 Mn |
| Jun 30, 2022 | 178.56 Mn |
| Dec 31, 2021 | 189.51 Mn |
| Jun 30, 2021 | 217.86 Mn |
| Dec 31, 2020 | 84.26 Mn |
| Dec 31, 2019 | 105.89 Mn |
API Access
Adagene Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ADAG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ADAG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ADAG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();